Financial Report

Consolidated income statement

1 January - 31 December

kEUR

Note

2021

2020

 

 

 

 

Revenue

3

282,126

223,033

Other operating income

3

4,091

1,778

Total income

 

286,217

224,811

 

 

 

 

Cost of sales

 

-182,426

-151,108

Gross profit

 

103,791

73,703

 

 

 

 

Marketing and sales expenses

3

-3,864

-3,640

Research expenses

3

-1,407

-1,312

General and administrative expenses

3

-34,355

-24,373

Total operating expenses

 

-39,626

-29,325

 

 

 

 

Operating result (EBIT)

 

64,165

44,378

 

 

 

 

Financial income

3

653

106

Financial expenses

3

-4,970

-6,799

Total financial result

 

-4,317

-6,693

 

 

 

 

Result before income taxes

 

59,848

37,685

 

 

 

 

Income tax charges

5

-12,590

-6,350

Result for the year

 

47,258

31,335

 

 

 

 

Attributable to shareholders of PolyPeptide Group AG

 

47,258

31,335

 

 

 

 

Earnings per share in EUR, basic

7

1.47

1.04

Earnings per share in EUR, diluted

7

1.47

1.04